Pharmaceutical

Tevogen Bio partners Microsoft for HPV treatment

Tevogen Bio’s AI effort Tevogen.AI has partnered with Microsoft to advance the development of an HPV specific CTL treatment.

Nov 7, 2024 - 06:00
Tevogen Bio partners Microsoft for HPV treatment
Tevogen Bio’s AI effort Tevogen.AI has partnered with Microsoft to advance the development of an HPV specific CTL treatment.
Read the original article

Tags:

Previous Article

GSK CEO addresses declining trust in vaccines following Trump re-election

Next Article

Trump triumphs but impact on healthcare industry remains unclear

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Enanta secures FDA fast track designation for EDP-323 to treat RSV

Enanta secures FDA fast track designation for EDP-323 t...

Apr 8, 2023

Opinion: Hospital systems have to decide: Do they want to be Apple or Android?

Opinion: Hospital systems have to decide: Do they want ...

Nov 15, 2023

FDA approves Duchenne gene therapy with hefty $3.2m price tag

FDA approves Duchenne gene therapy with hefty $3.2m pri...

Jun 23, 2023